StockData
Haemonetics Corp logo

Haemonetics Corp (HAE) stock

HAENYSESurgical & Medical Instruments & ApparatusFiscal year ends April 3
Financials through Q1 FY2027, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3075% above fair value
$120.37−2.49 (-2.03%)

Close on Nov 19, 2026Market cap $5.48BP/E 58.7Yield –

Haemonetics gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Haemonetics's gross profit for the twelve months ending Jun 27, 2026 was $798.15M, up 4.2% year over year. For fiscal 2026 it was $787.59M, up 5.2% from the year before. Over ten years it grew 6.9% a year on average. The highest annual figure on record is $787.59M in fiscal 2026.

Annual gross profit

PeriodPeriod endValueChange
FY2026Mar 28, 2026$787.59M+5.2%
FY2025Mar 29, 2025$748.96M+8.3%
FY2024Mar 30, 2024$691.55M+12.4%
FY2023Apr 1, 2023$615.10M+21.7%
FY2022Apr 2, 2022$505.50M+27.1%
FY2021Apr 3, 2021$397.84M-17.9%
FY2020Mar 28, 2020$484.51M+16.0%
FY2019Mar 30, 2019$417.54M+1.4%
FY2018Mar 31, 2018$411.91M+8.8%
FY2017Apr 1, 2017$378.49M-6.8%
FY2016Apr 2, 2016$405.91M-6.6%
FY2015Mar 28, 2015$434.42M-7.2%
FY2014Mar 29, 2014$468.37M+9.4%
FY2013Mar 30, 2013$428.13M+15.9%
FY2012Mar 31, 2012$369.24M+4.0%
FY2011Apr 2, 2011$355.21M+5.3%
FY2010Apr 3, 2010$337.48M+9.5%
FY2009Mar 28, 2009$308.17M–

Quarterly gross profit

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 27, 2026$202.80M+5.5%
Q4 FY2026CQ1 2026Mar 28, 2026$198.21M+2.7%
Q3 FY2026CQ4 2025Dec 27, 2025$202.39M+4.6%
Q2 FY2026CQ3 2025Sep 27, 2025$194.74M+3.9%
Q1 FY2026CQ2 2025Jun 28, 2025$192.24M+9.9%
Q4 FY2025CQ1 2025Mar 29, 2025$193.05M+9.7%
Q3 FY2025CQ4 2024Dec 28, 2024$193.55M+8.8%
Q2 FY2025CQ3 2024Sep 28, 2024$187.44M+9.9%
Q1 FY2025CQ2 2024Jun 29, 2024$174.92M+4.6%
Q4 FY2024CQ1 2024Mar 30, 2024$175.91M+12.6%
Q3 FY2024CQ4 2023Dec 30, 2023$177.87M+12.1%
Q2 FY2024CQ3 2023Sep 30, 2023$170.51M+8.0%
Q1 FY2024CQ2 2023Jul 1, 2023$167.27M+17.6%
Q4 FY2023CQ1 2023Apr 1, 2023$156.25M+14.6%
Q3 FY2023CQ4 2022Dec 31, 2022$158.71M+14.5%
Q2 FY2023CQ3 2022Oct 1, 2022$157.88M+28.8%
Q1 FY2023CQ2 2022Jul 2, 2022$142.26M+31.6%
Q4 FY2022CQ1 2022Apr 2, 2022$136.31M+66.6%
Q3 FY2022CQ4 2021Jan 1, 2022$138.57M+15.2%
Q2 FY2022CQ3 2021Oct 2, 2021$122.54M+15.9%
Q1 FY2022CQ2 2021Jul 3, 2021$108.09M+20.1%
Q4 FY2021CQ1 2021Apr 3, 2021$81.81M-28.0%
Q3 FY2021CQ4 2020Dec 26, 2020$120.26M-6.1%
Q2 FY2021CQ3 2020Sep 26, 2020$105.74M-16.7%
Q1 FY2021CQ2 2020Jun 27, 2020$90.03M-22.3%
Q4 FY2020CQ1 2020Mar 28, 2020$113.56M+2.1%
Q3 FY2020CQ4 2019Dec 28, 2019$128.05M+15.2%
Q2 FY2020CQ3 2019Sep 28, 2019$127.00M+13.5%
Q1 FY2020CQ2 2019Jun 29, 2019$115.91M+39.2%
Q4 FY2019CQ1 2019Mar 30, 2019$111.21M+6.5%
Q3 FY2019CQ4 2018Dec 29, 2018$111.18M-0.1%
Q2 FY2019CQ3 2018Sep 29, 2018$111.91M+7.0%
Q1 FY2019CQ2 2018Jun 30, 2018$83.24M-9.2%
Q4 FY2018CQ1 2018Mar 31, 2018$104.39M+27.1%
Q3 FY2018CQ4 2017Dec 30, 2017$111.30M+10.1%
Q2 FY2018CQ3 2017Sep 30, 2017$104.56M+0.3%
Q1 FY2018CQ2 2017Jul 1, 2017$91.67M–
Q4 FY2017CQ1 2017Apr 1, 2017$82.11M–
Q3 FY2017CQ4 2016Dec 31, 2016$101.08M–
Q2 FY2017CQ3 2016Oct 1, 2016$104.25M–

More Haemonetics figures

See a number that looks wrong?